← FDA DRUG APPROVALS

FDA ANDA · ANDA074825

ATRACURIUM BESYLATE PRESERVATIVE FREE

Sponsor: BAXTER HLTHCARE

APPLICATION
ANDA074825
TYPE
ANDA
ORIGINAL APPROVAL
1997-09-30
LATEST ACTION
2000-04-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ATRACURIUM BESYLATE PRESERVATIVE FREEDiscontinued
ATRACURIUM BESYLATE 10MG/ML · INJECTABLE · INJECTION

Approval history

2000-04-06Manufacturing (CMC) · Supplement 3AP
1998-02-09Manufacturing (CMC) · Supplement 2AP
1998-02-09Manufacturing (CMC) · Supplement 1AP
1997-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →